The 21 references in paper L. Ikryannikova N., M. Senina E., E. Lisitsina S., L. Ogorodova M., S. Fedosenko V., M. Karnaushkina A., E. Il'ina N., Л. Икрянникова Н., М. Сенина Е., Е. Лисицина С., Л. Огородова М., С. Федосенко В., М. Карнаушкина А., Е. Ильина Н. (2015) “Видовая идентификация и анализ генетических маркеров лекарственной устойчивости стрептококков с помощью количественной мультиплексной полимеразной цепной реакции у пациентов с хронической обструктивной болезнью легких // Multiplex quantitative PCR for Streptococci species identification and detection of genetic drug resistance markers in COPD patients” / spz:neicon:pulmonology:y:2014:i:6:p:40-48

1
Зубков М.Н., Гугуцидзе Е.Н. Микробиологические аспекты диагностики пневмоний. Пульмонология. 1997; 1: 41–45.
(check this in PDF content)
2
Cabrera-Rubio R., Garcia-Núñez M., SetóL. et al. Microbiome diversity in the bronchial tracts of patients with chronic obstructive pulmonary disease. J. Clin. Microbiol. 2012; 50: 3562–3568.
(check this in PDF content)
3
Garcha D.S.,Thurston S.J., Patel A.R. et al. Changes in prevalence and load of air way bacteria using quantitative PCR in stable and exacerbated COPD. Thorax. 2012; 67: 1075–1080.
(check this in PDF content)
4
Monso E., Rosell A., Bonet G. Risk factors for lower air way colonization in chronic bronchitis. Eur. Respir. J.1999; 13: 338–342.
(check this in PDF content)
5
Sethi S., Murphy T.F. Infection in the pathogensis and course of chronic obstructive pulmonary disease. N. Engl. J. Med. 2008; 359: 2355–2365. Таблица 3 Анализ корреляционных связей между представленностью генов mef и еrmB клинико@анамнестическими характеристиками больных Table 3 Relationships between mef and еrmB genes and clinical features of the patients Представленность гена Клинико!амнестический признакnrp в образце mefЧастота обострений880,250,018 mefЧастота курсов АБТ880,270,010 ermBЧастота обострений870,300,0045 ermBЧастота курсов АБТ870,490,000002 ermBПродукция мокроты870,300,0045 ermBИК870,320,0022 Оригинальные исследования
(check this in PDF content)
6
Sehti S., Evans N., Grant B.J.B., Murphy T.F.N. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. Engl. J. Med.2002; 347: 465–471.
(check this in PDF content)
7
Facklam R. What happed to the streptococci: overview of taxonomic and nomenclature changes. Clin. Microbiol. Rev. 2002; 15: 613–630.
(check this in PDF content)
8
Facklam R., Pigott N. Description of phenotypic characteristics to aid in the identification of Streptococcus pneumonia. In: Totollan A., ed. Pathogenic streptococci: present and future. St. Petersburg: Lancer Publications; 1994.
(check this in PDF content)
9
Pikis A., Campos J.M., Rodriguez W.J., Keith J.M. Optochin resistance in Streptococcus pneumoniae: mechanism, significance and clinical implications. J. Infect. Dis. 2001; 184: 582–590.
(check this in PDF content)
10
Obregon V., Garcia P., Garcia E. et al. Molecular peculiarities of the lytA gene isolated from clinical pneumococcal strains that are bile insoluble.J. Clin. Microbiol.2002; 40: 2545–2554.
(check this in PDF content)
11
Corless C.E., Guiver M., Borrow R. et al. Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR.J. Clin. Microbiol.2001; 39: 1553–1558.
(check this in PDF content)
12
McAvin J.C., Reilly P.A., Lohman K.L. Sensitive and specific method for rapid identification of Streptococcus pneumoniae using real-time fluorescence PCR. J. Clin. Microbiol.2001; 39: 3446–3451.
(check this in PDF content)
13
Чучалин А.Г., ред. Пульмонология. Национальное руководство. М.: ГЭОТАР-Медиа; 2013.
(check this in PDF content)
14
Reinert R.R., Ringelstein A., van der Linden M. et al. Molecular epidemiology of macrolide-resistant Streptococcus pneumoniae isolates in Europe. J. Clin. Microbiol. 2005; 43: 1294–1300.
(check this in PDF content)
15
Страчунский Л.С., Кречикова О.И., Решедько Г.К. и др. Чувствительность к антибиотикам пневмококков, выделенных от здоровых детей из организованных коллективов.Клиническая микробиология и антимикробная химиотерапия.1999; 1 (1): 31–39.
(check this in PDF content)
16
Farrell D.J., Morrissey I., Bakker S. et al. Molecular Epidemiology of multiresistant Streptococcus pneumoniae with both erm(B)- and mef(A)-mediated macrolide resistance.J. Clin. Microbiol.2004; 42: 764–768.
(check this in PDF content)
17
Ikryannikova L.N., Filimonova A.V., Malakhova M.V. et al. Discrimination between Streptococcus pneumoniae and Streptococcus mitis based on sorting of their MALDI mass spectra.Clin. Microbiol. Infect.2013; 11: 1066–1071.
(check this in PDF content)
18
Ikryannikova L.N., Lapin K.N., Malakhova M.V. et al. Misidentification of alpha-hemolytic streptococci by routine tests in clinical practice. Infect. Genet. Evol.2011; 11: 1709–1715.
(check this in PDF content)
19
Preston J.A., Dockrell D.H. Virulence factors in pneumococcal respiratory pathogenesis.Future Microbiol. 2008; 2:
(check this in PDF content)
20
221. 20. Roberts A.P., Mullany P. A modular master on the move: the Tn916 family of mobile genetic elements. Trends Microbiol. 2009; 17: 251–258.
(check this in PDF content)
21
Del Grosso M., Camilli R., Iannelli F. et al. The mef(E)carrying genetic element (mega) of Streptococcus pneumoniae: Insertion sites and association with other genetic elements.Antimicrob. Agents Chemother.2006; 50: 3361–3366. Поступила 11.11.14
(check this in PDF content)